Useful information

Prime News delivers timely, accurate news and insights on global events, politics, business, and technology

Eli Lilly’s weight-loss drug tirzepatide wins UK NICE endorsement


Two measuring pens of a fictitious drug semaglutide (GLP-1) on a scale in front of a weight. Concept of alternative ways to lose weight.

aprott/iStock via Getty Images

  • The UK’s medicines cost-effectiveness monitoring organisation, the National Institute for Health and Care Excellence (“NICE”), has formally recommended Eli LillyNew York Stock Exchange:LLY) GLP-1 tirzepatide as a treatment for weight loss.
  • The drug is sold under the name Zepbound for weight loss.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *